INCREASED EXPRESSION OF SEMAPHORIN 4A IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS ASSOCIATION WITH THE ACTIVITY OF LUPUS NEPHRITIS

被引:0
|
作者
Choi, Y. [1 ]
Lee, E. K. [2 ]
Kim, K. M. [3 ]
Lee, M. S. [4 ]
Lee, C. H. [4 ]
Chung, C. H. [4 ]
Yoo, W. H. [1 ]
机构
[1] Jeonbuk Natl Univ, Internal Med, Sch Med, Jeonju, South Korea
[2] Jeonbuk Natl Univ, Med Sci, Jeonju, South Korea
[3] Jeonbuk Natl Univ, Pathol, Sch Med, Jeonju, South Korea
[4] Wonkwang Univ Hosp, Internal Med, Iksan, South Korea
关键词
Systemic lupus erythematosus; Biomarkers; Animal models;
D O I
10.1136/annrheumdis-2023-eular.1251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0114
引用
收藏
页码:1235 / 1236
页数:2
相关论文
共 50 条
  • [31] SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
    Yang, Chi-Hui
    Wang, Xin-Yi
    Zhang, Yi-Hui
    Ding, Ning
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [32] Antinucleosome antibodies in systemic lupus erythematosus patients: Relation to disease activity and lupus nephritis
    Elessawi, Dina F.
    Mahmoud, Geilan A.
    El-Sawy, Wael S.
    Shieba, Hala F.
    Goda, Shimaa M.
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (01): : 31 - 34
  • [33] Evaluation of visfatin in patients with systemic lupus erythematosus: Correlation with disease activity and lupus nephritis
    Fouda, Neveen
    Abaza, Nouran
    El-Hilaly, Rana
    El Said, Heba W.
    EL-kabarity, Rania H.
    EGYPTIAN RHEUMATOLOGIST, 2012, 34 (01): : 9 - 17
  • [34] SERUM RESISTIN LEVEL IN SYSTEMIC LUPUS ERYTHEMATOSUS: RELATION TO LUPUS NEPHRITIS AND DISEASE ACTIVITY
    Ismail, F.
    Salah, S.
    Abdelhamed, M.
    Ela, M. Aboel
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1504 - 1504
  • [35] Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus
    Yang, Tzu-Han
    Wu, Tsai-Hung
    Chang, Yuh-Lih
    Liao, Hsien-Tzung
    Hsu, Chia-Chen
    Tsai, Chang-Youh
    Chou, Yueh-Ching
    CLINICAL NEPHROLOGY, 2018, 89 (04) : 277 - 285
  • [36] Cost of illness: Systemic lupus erythematosus versus lupus nephritis
    Eisenberg, D. F.
    Zhao, N.
    Hsu, B.
    Wu, Y.
    Renahan, K.
    Han, C.
    Bala, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 260 - 260
  • [37] LUPUS NEPHRITIS PROFILE IN TUNISIAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Cherichi, M.
    Boussoukaya, Y.
    Elghali, M.
    Sakly, N.
    Jguirim, M.
    Hammami, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1048 - 1048
  • [38] The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis
    Adhya, Zoe
    Borozdenkova, Svetlana
    Karim, Mohammed Yousuf
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3273 - 3280
  • [39] Lupus nephritis prolongs improvement of serositis in systemic lupus erythematosus
    Harada, Takuya
    Yamashita, Hiroyuki
    Nakajima, Sotaro
    Kobayashi, Toshiaki
    Takahashi, Hiroyuki
    Kaneko, Hiroshi
    JOINT BONE SPINE, 2024, 91 (04)
  • [40] Lupus Nephritis Susceptibility Loci in Women with Systemic Lupus Erythematosus
    Chung, Sharon A.
    Brown, Elizabeth E.
    Williams, Adrienne H.
    Ramos, Paula S.
    Berthier, Celine C.
    Bhangale, Tushar
    Alarcon-Riquelme, Marta E.
    Behrens, Timothy W.
    Criswell, Lindsey A.
    Graham, Deborah Cunninghame
    Demirci, F. Yesim
    Edberg, Jeffrey C.
    Gaffney, Patrick M.
    Harley, John B.
    Jacob, Chaim O.
    Kamboh, M. Ilyas
    Kelly, Jennifer A.
    Manzi, Susan
    Moser-Sivils, Kathy L.
    Russell, Laurie P.
    Petri, Michelle
    Tsao, Betty P.
    Vyse, Tim J.
    Zidovetzki, Raphael
    Kretzler, Matthias
    Kimberly, Robert P.
    Freedman, Barry I.
    Graham, Robert R.
    Langefeld, Carl D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (12): : 2859 - 2870